Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Return on Sales (2023 - 2024)

Contineum Therapeutics (CTNM) has 2 years of Return on Sales data on record, last reported at 0.38% in Q1 2024.

  • For Q1 2024, Return on Sales fell 5205.0% year-over-year to 0.38%; the TTM value through Mar 2024 reached 0.38%, changed N/A, while the annual FY2023 figure was 0.45%, N/A changed from the prior year.
  • Return on Sales reached 0.38% in Q1 2024 per CTNM's latest filing, down from 0.46% in the prior quarter.
  • Across five years, Return on Sales topped out at 52.43% in Q1 2023 and bottomed at 0.38% in Q1 2024.